MARTA CIPRIANI

Dottoranda

ciclo: XXXVIII
email:





Produzione scientifica

  • 11573/1682316 - 2023 - Addition of venetoclax to FLAI induction chemotherapy (VFLAI) improves survival in patients with intermediate and high-risk AML vs FLAI and 3+7: A GIMEMA Italian cooperative analysis (04c Atto di convegno in rivista)
    MARTA CIPRIANI, Giovanni MARCONI, FRANCESCA PAOLONI, GIORGIA SIMONETTI, Paola FAZI, Marco VIGNETTI, ALFONSO PICIOCCHI
  • 11573/1689339 - 2023 - P523: The comparison of VFLAI, FLAI and 3 + 7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low risk aml treated in Gimema trials real world (04c Atto di convegno in rivista)
    ALFONSO PICIOCCHI, Giovanni MARCONI, MARTA CIPRIANI, MONICA MESSINA, FRANCESCA PAOLONI, GIORGIA SIMONETTI, Paola FAZI, Marco VIGNETTI
  • 11573/1689341 - 2023 - P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL-WORLD SETTING (04c Atto di convegno in rivista)
    BEATRICE BORSELLINO, ALFONSO PICIOCCHI, MARTA CIPRIANI
  • 11573/1689338 - 2023 - P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE (04c Atto di convegno in rivista)
    ALFONSO PICIOCCHI, MARTA CIPRIANI, MONICA MESSINA, Giovanni MARCONI, VALENTINA ARENA, Paola FAZI, Marco VIGNETTI
  • 11573/1684559 - 2023 - Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting (01a Articolo in rivista)
    BEATRICE BORSELLINO, MARTA CIPRIANI
  • 11573/1692321 - 2023 - The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trial (01a Articolo in rivista)
    MARTA CIPRIANI, FLORIANA PICHIORRI, EMMA COLAMARINO, JLENIA TOPPI, Federica Tamburella, Giovanni Morone, FRANCESCO SAVERIO TOMAIUOLO, FILIPPO SANTORO, FEBO CINCOTTI
  • 11573/1689335 - 2023 - Pseudo-observations in survival analysis (04b Atto di convegno in volume)
    MARTA CIPRIANI, ALFONSO PICIOCCHI, VALENTINA ARENA, Marco ALFO'
  • 11573/1689336 - 2023 - S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY (04c Atto di convegno in rivista)
    FABIO EFFICACE, ALFONSO PICIOCCHI, MARTA CIPRIANI
  • 11573/1668672 - 2022 - The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials (04c Atto di convegno in rivista)
    ALFONSO PICIOCCHI, MONICA MESSINA, MARTA CIPRIANI, FRANCESCA PAOLONI, GIORGIA SIMONETTI, Giovanni MARCONI, Paola FAZI, Marco VIGNETTI
  • 11573/1672711 - 2022 - Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors (04c Atto di convegno in rivista)
    ALFONSO PICIOCCHI, MARTA CIPRIANI, FABIO EFFICACE


Le attività presentate in questa pagina sono finanziate totalmente, o in parte, dai fondi del Piano nazionale di ripresa e resilienza.
L'elenco e le finalità delle attività intraprese dalla Sapienza sono descritte nella pagina dedicata Sapienza per il Pnrr.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma